In this piece, we explore reasons for creating a separate conversion factor within the MPFS, initially for advanced primary ...

Health Affairs' Rob Lott interviews Tiffany Lemon of Arizona State University on her recent paper exploring the concept of ...

With a Senate vote looming and reports of an impending White House proposal, this article discusses what has transpired in ...

The Antimicrobial Resistance Strategic Coalition is proof that when experts unite around shared goals, they can drive real change, even in the absence of formal government mandates.

A 2026 CMS proposed rule contains multiple provisions that will improve the transparency of hospital prices and support the ...

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

With collaboration and evidence-based approaches, we can build a patient-centric health care system that works better for ...

The real gold standard for science, and academic freedom, requires upholding scientific work that investigates who and what ...

The 340B rebate pilot model set to begin in January 2026 starkly presents the key tradeoff between program integrity and ...

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...